Journal article icon

Journal article

Possible mediators of metabolic endotoxemia in women with obesity and women with obesity-diabetes in The Gambia

Abstract:
AIMS/HYPOTHESIS: Translocation of bacterial debris from the gut causes metabolic endotoxemia (ME) that results in insulin resistance, and may be on the causal pathway to obesity-related type 2 diabetes. To guide interventions against ME we tested two hypothesised mechanisms for lipopolysaccharide (LPS) ingress: a leaky gut and chylomicron-associated transfer following a high-fat meal. METHODS: In lean women (n = 48; fat mass index (FMI) 9.6 kg/m2), women with obesity (n = 62; FMI 23.6 kg/m2) and women with obesity-diabetes (n = 38; FMI 24.9 kg/m2) we used the lactulose-mannitol dual-sugar permeability test (LM ratio) to assess gut integrity. Markers of ME (LPS, EndoCAb IgG and IgM, IL-6, CD14 and lipoprotein binding protein) were assessed at baseline, 2 h and 5 h after a standardised 49 g fat-containing mixed meal. mRNA expression of markers of inflammation, macrophage activation and lipid metabolism were measured in peri-umbilical adipose tissue (AT) biopsies. RESULTS: The LM ratio did not differ between groups. LPS levels were 57% higher in the obesity-diabetes group (P < 0.001), but, contrary to the chylomicron transfer hypothesis, levels significantly declined following the high-fat challenge. EndoCAb IgM was markedly lower in women with obesity and women with obesity-diabetes. mRNA levels of inflammatory markers in adipose tissue were consistent with the prior concept that fat soluble LPS in AT attracts and activates macrophages. CONCLUSIONS/INTERPRETATION: Raised levels of LPS and IL-6 in women with obesity-diabetes and evidence of macrophage activation in adipose tissue support the concept of metabolic endotoxemia-mediated inflammation, but we found no evidence for abnormal gut permeability or chylomicron-associated post-prandial translocation of LPS. Instead, the markedly lower EndoCAb IgM levels indicate a failure in sequestration and detoxification
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1038/s41366-022-01193-1
Publication website:
https://www.nature.com/articles/s41366-022-01193-1.pdf

Authors

More by this author
Role:
Author
ORCID:
0000-0001-5309-5611
More by this author
Role:
Author
ORCID:
0000-0002-0648-3336
More by this author
Role:
Author
ORCID:
0000-0002-3100-8799
More by this author
Role:
Author
ORCID:
0000-0002-9415-1218


Publisher:
Springer Nature [academic journals on nature.com]
Journal:
International Journal of Obesity More from this journal
Volume:
46
Issue:
10
Pages:
1892-1900
Publication date:
2022-08-06
DOI:
EISSN:
1476-5497
ISSN:
0307-0565


Language:
English
Keywords:
Pubs id:
1273682
Local pid:
pubs:1273682
Source identifiers:
W4290034036
Deposit date:
2026-04-27
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP